IL104775A - Pharmaceutical composition containing triazine derivatives for treating pain or oedema - Google Patents

Pharmaceutical composition containing triazine derivatives for treating pain or oedema

Info

Publication number
IL104775A
IL104775A IL10477593A IL10477593A IL104775A IL 104775 A IL104775 A IL 104775A IL 10477593 A IL10477593 A IL 10477593A IL 10477593 A IL10477593 A IL 10477593A IL 104775 A IL104775 A IL 104775A
Authority
IL
Israel
Prior art keywords
oedema
pharmaceutical composition
composition containing
treating pain
triazine derivatives
Prior art date
Application number
IL10477593A
Other languages
English (en)
Other versions
IL104775A0 (en
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of IL104775A0 publication Critical patent/IL104775A0/xx
Publication of IL104775A publication Critical patent/IL104775A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL10477593A 1992-02-19 1993-02-18 Pharmaceutical composition containing triazine derivatives for treating pain or oedema IL104775A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929203483A GB9203483D0 (en) 1992-02-19 1992-02-19 Anti-inflammatory compounds

Publications (2)

Publication Number Publication Date
IL104775A0 IL104775A0 (en) 1993-06-10
IL104775A true IL104775A (en) 1997-02-18

Family

ID=10710643

Family Applications (1)

Application Number Title Priority Date Filing Date
IL10477593A IL104775A (en) 1992-02-19 1993-02-18 Pharmaceutical composition containing triazine derivatives for treating pain or oedema

Country Status (18)

Country Link
US (1) US5712277A (pt)
EP (1) EP0626851B1 (pt)
KR (1) KR950700067A (pt)
AT (1) ATE204476T1 (pt)
AU (1) AU684711B2 (pt)
CA (1) CA2129043C (pt)
CY (1) CY2299B1 (pt)
DE (1) DE69330638T2 (pt)
DK (1) DK0626851T3 (pt)
ES (1) ES2162813T3 (pt)
GB (2) GB9203483D0 (pt)
GR (1) GR3036958T3 (pt)
IL (1) IL104775A (pt)
MX (1) MX9300927A (pt)
NZ (1) NZ249197A (pt)
PT (1) PT626851E (pt)
TW (1) TW226331B (pt)
WO (1) WO1993016700A1 (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9424766D0 (en) * 1994-12-07 1995-02-08 Wellcome Found Pharmaceutical composition
RU2145602C1 (ru) * 1994-12-30 2000-02-20 Де Вэллкам Фаундейшн Лимитед Способы получения ламотриджина, промежуточные соединения и способ получения фармацевтической композиции
GB9625795D0 (en) * 1996-12-12 1997-01-29 Smithkline Beecham Plc Novel treatment
GB9726987D0 (en) 1997-12-22 1998-02-18 Glaxo Group Ltd Compounds
ATE303162T1 (de) * 1999-04-09 2005-09-15 Euro Celtique Sa Natrium kanalblocker zusammensetzungen und deren verwendung
ES2253579T3 (es) 2001-09-03 2006-06-01 Newron Pharmaceuticals S.P.A. Composicion farmaceutica que comprende gabapentina o un analogo suyo y una alfa-aminoamida y su uso analgesico.
JP5319920B2 (ja) * 2004-09-10 2013-10-16 ニユーロン・フアーマシユーテイカルズ・エツセ・ピー・アー ナトリウムおよび／またはカルシウムチャンネル選択的調節因子として活性のある医薬の製造のための（ハロベンジルオキシ）ベンジルアミノ−プロパンアミドの使用
US10576086B2 (en) * 2015-06-12 2020-03-03 University Of Greenwich Triazine derivatives as interferon-gamma inhibitors

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3637688A (en) * 1970-01-09 1972-01-25 American Home Prod 6-(fluoro and trifluoromethyl phenyl)-3 5-diamino - 1 2 4 - triazines and substituted - 6 - phenylalkyl-3,5-diamino-1 2 4-triazines
US4310551A (en) * 1979-03-19 1982-01-12 Diamond Shamrock Corporation Pharmacologically active substituted 1,2,4-triazines
AU530999B2 (en) * 1979-06-01 1983-08-04 Wellcome Foundation Limited, The Substituted amino triazines and their use in treatment of cns disorders
GB8613183D0 (en) * 1986-05-30 1986-07-02 Wellcome Found Triazine salt
GB9012312D0 (en) * 1990-06-01 1990-07-18 Wellcome Found Pharmacologically active cns compounds

Also Published As

Publication number Publication date
GB9414348D0 (en) 1994-09-07
TW226331B (pt) 1994-07-11
IL104775A0 (en) 1993-06-10
PT626851E (pt) 2002-02-28
WO1993016700A1 (en) 1993-09-02
GB2277265A (en) 1994-10-26
CA2129043C (en) 2004-01-27
DE69330638T2 (de) 2002-06-27
US5712277A (en) 1998-01-27
NZ249197A (en) 1997-05-26
ATE204476T1 (de) 2001-09-15
CA2129043A1 (en) 1993-09-02
CY2299B1 (en) 2003-07-04
GB2277265B (en) 1996-01-10
MX9300927A (es) 1994-08-31
KR950700067A (ko) 1995-01-16
EP0626851B1 (en) 2001-08-22
GB9203483D0 (en) 1992-04-08
ES2162813T3 (es) 2002-01-16
AU3509293A (en) 1993-09-13
DK0626851T3 (da) 2001-12-03
JPH07503968A (ja) 1995-04-27
DE69330638D1 (de) 2001-09-27
GR3036958T3 (en) 2002-01-31
EP0626851A1 (en) 1994-12-07
JP3713271B2 (ja) 2005-11-09
AU684711B2 (en) 1998-01-08

Similar Documents

Publication Publication Date Title
IL110643A0 (en) Amidine derivatives, their preparation and pharmaceutical compositions containing them
UA39158C2 (uk) Похідні n4-оксикарбоніл-5'-дезокси-5-фторцитидину та фармацевтичний препарат на їх основі
BG101118A (en) Therapeutical compounds
ZA941530B (en) Use of lamotrigine in the treatment of neuro-AIDS
MY111260A (en) Pharmaceutical composition for the treatment of nicotine dependence
GR3036774T3 (en) Compositions containing G-CSF and TNF binding protein.
IL104775A (en) Pharmaceutical composition containing triazine derivatives for treating pain or oedema
AP9801286A0 (en) Therapeutic compounds.
DK0583026T3 (pt)
PL318130A1 (en) Terpenod derivatives (of sarcodictyine)as antineoplastic agents
PH20020A (en) New 5-methyl-6-phenyl-4,5-dihydro-1,2,4-triazine derivatives,their composition and use
GB9505082D0 (en) Medicament
HUP9802536A3 (en) Pharmaceutical compositions containing 1,2,4-benzotriazine 1,4-dioxide and use thereof for the preparation of pharmaceutical compositions treating cancer
WO1998025594A3 (en) Lamotrigine in the treatment and prophylaxis of migraine
ZA948908B (en) Use of 2-amino purine derivatives for the treatment and pro-phylaxis of human herpes virus 7 infection
GB2282326A (en) Use of 3,5-diamino-6-(2,3 dichlorophenyl)-1,2,4-triazine isethionate for the treatment and prevention of dependence,tolerance and sensitization of drugs
IL101284A (en) 2-arylimidazo 1, 5-a9 quinoxaline-1, 3(2h, 5h)-diones certain derivatives of tautomers thereof use of such compounds in the manufacture of medicaments and pharmaceutical compositions containing them
MX9709712A (es) Uso de derivados de 1,2,4-triazol para la manufactura de un medicamento para el tratamiento de canceres.

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
RH1 Patent not in force